ReviewFrontiers in endocrinology2022

Aumolertinib Effectively Reduces Clinical Symptoms of an EGFR L858R-Mutant Non-Small Cell Lung Cancer Case Coupled With Osimertinib-Induced Cardiotoxicity: Case Report and Review.

Qianqian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.